Advancement in Physiotherapy

There has been renewed interest in the spondyloarthropathy family of chronic inflammatory Pain medication conditions, which has been fuelled to a large extent by the biologic era. Over the period of the past 2 years in particular, there have been several notable advances. First, there have been a number of large, high-quality randomized controlled trials evaluating the tumor necrosis factor (TNF) blockers and conservative treatments such as physiotherapy and non-steroidal anti-inflammatory drugs for use in spondyloarthropathy. Operant behavioral and cognitive-behavioral treatment for chronic low back pain

 

Related Conference of Physical Therapy Rehabilitation